Arthritis Types: Osteoarthritis, Rheumatoid, and Psoriatic Compared

Three Diseases, One Name, Vastly Different Origins

More than 58 million American adults have some form of arthritis — a figure that makes it the nation's leading cause of disability. But "arthritis" is not a single disease. The term describes over 100 conditions affecting joints and surrounding tissues. Three forms dominate clinical practice: osteoarthritis (OA), rheumatoid arthritis (RA), and psoriatic arthritis (PsA). They share joint pain and inflammation as symptoms but differ fundamentally in cause, pattern of joint involvement, systemic manifestations, and treatment approach.

Getting the diagnosis right matters enormously. A patient with rheumatoid arthritis treated for osteoarthritis alone will experience unchecked immune-mediated joint destruction. A patient with osteoarthritis given aggressive immunosuppression faces unnecessary risks. Distinguishing between these conditions is one of the most clinically consequential tasks in internal medicine and rheumatology.

Osteoarthritis: Mechanical Failure of Cartilage

Osteoarthritis is the most common form of arthritis, affecting approximately 32.5 million American adults. It results from gradual degradation of articular cartilage — the protective tissue covering the ends of bones within joints. As cartilage breaks down, subchondral bone is exposed and may develop reactive bony growths (osteophytes). The synovium may become mildly inflamed, but OA is fundamentally a degenerative, mechanical condition rather than a systemic inflammatory disease.

Key Features of Osteoarthritis

• Joint distribution: Weight-bearing joints (knees, hips, lumbar spine, cervical spine), and the distal interphalangeal (DIP) joints of the fingers; typically asymmetric or unilateral
• Pain pattern: Worse with activity, better with rest; morning stiffness lasting less than 30 minutes
• Physical findings: Crepitus (grinding sensation), joint-line tenderness, bony enlargement (Heberden's nodes at DIP joints, Bouchard's nodes at PIP joints), reduced range of motion
• Imaging: X-rays show joint space narrowing, osteophytes, subchondral sclerosis, and cysts
• Systemic involvement: None — OA does not cause systemic inflammation, elevated inflammatory markers, or organ involvement

Risk factors include age (OA prevalence rises sharply after 45), obesity (mechanical loading and adipokine-mediated inflammation), prior joint injury (post-traumatic OA), female sex, and genetic predisposition (particularly for hand OA).

Rheumatoid Arthritis: Systemic Autoimmune Attack on Joints

Rheumatoid arthritis is a systemic autoimmune disease in which the immune system attacks synovial tissue — the membrane lining joint cavities. This produces chronic synovitis (inflammation of the synovial membrane), joint swelling, and if untreated, progressive joint erosion and destruction. RA affects approximately 1.3 million Americans and is two to three times more common in women than in men.

Key Features of Rheumatoid Arthritis

• Joint distribution: Small joints of the hands (MCPs, PIPs — notably sparing the DIP joints) and feet, wrists, elbows, and ankles; typically symmetric and bilateral
• Pain pattern: Worse in the morning; morning stiffness lasting more than 60 minutes (often hours); improves with activity
• Systemic features: Fatigue, low-grade fever, weight loss; extra-articular manifestations include rheumatoid nodules, interstitial lung disease, pericarditis, and secondary Sjögren's syndrome
• Laboratory findings: Rheumatoid factor (RF) positive in 60–80% of patients; anti-cyclic citrullinated peptide (anti-CCP) antibodies positive in 60–70% and are highly specific; elevated ESR and CRP; normocytic anemia
• Imaging: X-rays show periarticular osteopenia, joint space narrowing, and marginal erosions; MRI and ultrasound detect synovitis and erosions earlier than X-ray

Untreated RA causes irreversible joint damage measurable on X-ray within the first two years of disease. Early aggressive treatment is therefore a central principle of modern RA management.

Psoriatic Arthritis: Inflammation at the Skin-Joint Interface

Psoriatic arthritis is a chronic inflammatory arthritis occurring in association with psoriasis. Approximately 30 percent of people with psoriasis develop psoriatic arthritis. It is classified as a spondyloarthropathy — a family of inflammatory arthritides that also includes ankylosing spondylitis and reactive arthritis.

Key Features of Psoriatic Arthritis

• Joint distribution: Variable; may involve DIP joints (unlike RA), can be oligoarticular or polyarticular; affects the spine (spondylitis) and sacroiliac joints in approximately 40% of cases
• Dactylitis: "Sausage digit" — diffuse swelling of an entire finger or toe caused by both tendon sheath and joint inflammation; highly characteristic of PsA
• Enthesitis: Inflammation at sites where tendons and ligaments attach to bone (heel, plantar fascia, Achilles tendon); a hallmark of spondyloarthropathies
• Skin involvement: Psoriatic plaques typically precede arthritis by years but may develop concurrently or after; nail changes (pitting, onycholysis) are closely associated with DIP joint involvement
• Laboratory findings: RF and anti-CCP are typically negative (seronegative); inflammatory markers are elevated during active disease; HLA-B27 is positive in those with spinal involvement

Comparison of the Three Main Arthritis Types

Treatment Approaches by Type

The 2022 ACR guidelines for RA recommend treat-to-target strategies, aiming for disease remission or low disease activity measured by validated instruments (DAS28, CDAI, or SDAI). Tight disease control achieved through this approach has dramatically reduced rates of disability and joint replacement over the past two decades.

This article is for informational purposes only. Consult a qualified healthcare professional before making any health decisions.